The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
CDSCO to fast-track trials and approval for COVID19 vaccine
It is expected that the drug substance would be available from August 2021 which will be supplied back to Bharat Biotech for producing COVAXIN
Financial support is being provided as a grant from the Government of India
In animal health, the products will be mainly targeting mastitis and production disorders, gastrointestinal tract diseases, reproductive disorders, ectoparasites, and skin injuries
Subscribe To Our Newsletter & Stay Updated
